Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4402 Target Snapshot

Retinoic acid receptor RXR-gamma · SINGLE PROTEIN · Mus musculus

88Compounds
20Assays
7Approved Drugs
139.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P28705. Use UniProt P28705 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P28705 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Retinoic acid receptor RXR-gamma as ChEMBL target CHEMBL4402, mapped to UniProt P28705. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Retinoic acid receptor RXR-gamma
SINGLE PROTEIN · Mus musculus
As of 2026-09-13
ChEMBL target ID
CHEMBL4402
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P28705
Retinoic acid receptor RXR-gamma
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Retinoic acid receptor RXR-gamma is the right protein anchor across sources, using UniProt P28705 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelRetinoic acid receptor RXR-gamma
UniProt AccessionP28705
Component TypeProtein
Sequence Length463 aa

Retinoic acid receptor RXR-gamma

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Retinoic acid receptor RXR-gamma, mapped to UniProt P28705. Sequence length is 463 aa.

Mapped IDP28705
Review nameRetinoic acid receptor RXR-gamma
OrganismMus musculus
Clinical Profile

Clinical Phase Distribution

7
Approved
Assay Mix

Activity Type Distribution

IC504.0
KI29.0
EC5062.0
KD44.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL310047 8.52 EC50 3.0 Preclinical
CHEMBL288436 8.52 Kd 3.0 Preclinical
CHEMBL288436 8.4 EC50 4.0 Preclinical
CHEMBL705 8.4 Kd 4.0 Approved
CHEMBL109117 8.3 EC50 5.0 Preclinical
CHEMBL80236 8.3 Ki 5.0 Preclinical
CHEMBL310047 8.3 Ki 5.0 Preclinical
CHEMBL38 8.22 EC50 6.0 Approved
CHEMBL80236 8.22 EC50 6.0 Preclinical
CHEMBL312395 8.15 Ki 7.0 Preclinical
Distribution

pChEMBL Value Distribution

3
5.0
7
5.5
22
6.0
25
6.5
18
7.0
18
7.5
9
8.0
2
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

ALITRETINOIN
CHEMBL705
Approved 1999
BEXAROTENE
CHEMBL1023
Approved 1999
TRETINOIN
CHEMBL38
Approved 1971
Assay Landscape

Assay Landscape

20
Total Assays
95
Tested Compounds
2
Assay Types
Binding — 15 assays, 95 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 7 35 7.0
single protein format 7 46 6.9
assay format 1 14 6.9
Functional — 5 assays, 4 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 5 4 7.3

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine